Ken Griffin Integra Lifesciences Holdings Corp Put Options Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$23.14 - $34.72 $37,024 - $55,552
1,600 Added 61.54%
4,200 $122,000
Q1 2024

May 15, 2024
BUY
$33.4 - $45.2 $86,840 - $117,520
2,600 New
2,600 $92,000
Q1 2023

May 15, 2023
SELL
$52.61 - $60.49 $1.1 Million - $1.26 Million
-20,900 Reduced 90.48%
2,200 $126,000
Q4 2022

Feb 14, 2023
BUY
$42.17 - $58.6 $708,456 - $984,480
16,800 Added 266.67%
23,100 $1.3 Million
Q3 2022

Nov 14, 2022
BUY
$42.28 - $57.17 $266,364 - $360,171
6,300 New
6,300 $267,000

Others Institutions Holding IART

# of Institutions
255
Shares Held
75.5M
Call Options Held
10.7K
Put Options Held
57.7K
View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

IART Quotes by TradingView
  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.46B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email